Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 18, 2017
Previous Article Next Article

Tissue chips – innovative tools for drug development and disease modeling

Author affiliations

Abstract

The high rate of failure during drug development is well-known, however recent advances in tissue engineering and microfabrication have contributed to the development of microphysiological systems (MPS), or ‘organs-on-chips’ that recapitulate the function of human organs. These ‘tissue chips’ could be utilized for drug screening and safety testing to potentially transform the early stages of the drug development process. They can also be used to model disease states, providing new tools for the understanding of disease mechanisms and pathologies, and assessing effectiveness of new therapies. In the future, they could be used to test new treatments and therapeutics in populations – via clinical trials-on-chips – and individuals, paving the way for precision medicine. Here we will discuss the wide-ranging and promising future of tissue chips, as well as challenges facing their development.

Graphical abstract: Tissue chips – innovative tools for drug development and disease modeling

Back to tab navigation

Article information


Submitted
28 Apr 2017
Accepted
03 Aug 2017
First published
10 Aug 2017

Lab Chip, 2017,17, 3026-3036
Article type
Critical Review

Tissue chips – innovative tools for drug development and disease modeling

L. A. Low and D. A. Tagle, Lab Chip, 2017, 17, 3026
DOI: 10.1039/C7LC00462A

Social activity

Search articles by author

Spotlight

Advertisements